A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs? (vol 77, pg 1115, 2017)

被引:2
|
作者
St Peter, Wendy L. [1 ]
Wazny, Lori D. [2 ,3 ]
Weinhandl, Eric [1 ]
Cardone, Katie E. [4 ]
Hudson, Joanna Q. [5 ,6 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
[2] Manitoba Renal Program, Winnipeg, MB, Canada
[3] Winnipeg Reg Hlth Author Pharm Program, Winnipeg, MB, Canada
[4] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY USA
[5] Univ Tennessee, Coll Pharm, Dept Clin Pharm, Memphis, TN USA
[6] Univ Tennessee, Dept Med, Memphis, TN USA
关键词
D O I
10.1007/s40265-017-0798-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1611 / 1611
页数:1
相关论文
共 50 条
  • [41] Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
    Jamal, Sophie A.
    Vandermeer, Ben
    Raggi, Paolo
    Mendelssohn, David C.
    Chatterley, Trish
    Dorgan, Marlene
    Lok, Charmaine E.
    Fitchett, David
    Tsuyuki, Ross T.
    [J]. LANCET, 2013, 382 (9900): : 1268 - 1277
  • [42] Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease (vol 92, pg 625, 2017)
    Li, L.
    Lai, E. Y.
    Luo, Z.
    [J]. KIDNEY INTERNATIONAL, 2017, 92 (06) : 1558 - 1558
  • [43] Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45mL/min/1.73m2) (vol 32, pg 9, 2017)
    Farrington, Ken
    Covic, Adrian
    Aucella, Filippo
    Clyne, Naomi
    de Vos, Leen
    Findlay, Andrew
    Fouque, Denis
    Grodzicki, Tomasz
    Iyasere, Osasuyi
    Jager, Kitty J.
    Joosten, Hanneke
    Macias, Juan Florencio
    Mooney, Andrew
    Nitsch, Dorothea
    Stryckers, Marijke
    Taal, Maarten
    Tattersall, James
    Van Asselt, Dieneke
    Van den Noortgate, Nele
    Nistor, Ionut
    Van Biesen, Andwim
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (04) : 740 - 740
  • [45] Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis (vol 26, pg 1407, 2023)
    McEwan, P.
    Hafner, M.
    Jha, V.
    Correa-Rotter, R.
    Chernin, G.
    De Nicola, L.
    Villanueva, R.
    Wheeler, D. C.
    Barone, S.
    Nolan, S.
    Sanchez, J. J. Garcia
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 165 - 166
  • [46] Do Implantable Cardioverter Defibrillators Reduce Mortality in Patients With Chronic Kidney Disease at All Stages?: An Updated Meta-Analysis (vol 58, pg 371, 2017)
    Fu, Linghua
    Zhou, Qiongqiong
    Zhu, Wengen
    Huang, Lin
    Ding, Ying
    Shen, Yang
    Hu, Jinzhu
    Hong, Kui
    [J]. INTERNATIONAL HEART JOURNAL, 2017, 58 (05) : 835 - 836
  • [48] Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis
    Tsai, Wan-Chuan
    Wu, Hon-Yen
    Peng, Yu-Sen
    Hsu, Shih-Ping
    Chiu, Yen-Ling
    Chen, Hung-Yuan
    Yang, Ju-Yeh
    Ko, Mei-Ju
    Pai, Mei-Fen
    Tu, Yu-Kang
    Hung, Kuan-Yu
    Chien, Kuo-Liong
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (11) : 1977 - 1983
  • [49] Effect of Dietary Potassium Restriction on Serum Potassium, Disease Progression, and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis (vol 30, pg 276, 2020)
    Morris, Andrew
    Krishnan, Nithya
    Kimani, Peter K.
    Lycett, Deborah
    [J]. JOURNAL OF RENAL NUTRITION, 2022, 32 (01) : E1 - E10
  • [50] Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters (vol 92, pg 26, 2017)
    Ketteler, M.
    Block, G. A.
    Evenepoel, P.
    [J]. KIDNEY INTERNATIONAL, 2017, 92 (06) : 1558 - 1558